Overview

Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Patient on an intermittent androgen deprivation protocol for biochemical recurrence after radical local therapy for prostate cancer,the addition of continuous dutasteride treatment, significantly prolongs the duration of the off treatment interval and time to androgen independence.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Canadian Urology Research Consortium
Collaborator:
GlaxoSmithKline
Treatments:
Androgens
Dutasteride